IHS Poster Library

IHC poster presenters are offered the opportunity to extend the life of their poster by posting it on the IHS website.

The posters are available as downloadable PDF files.

You can search the posters by congress year, category or a title word, or browse all the posters below the search box.

All poster content is the responsibility of the authors.

Search results

244 Results
Category Title Email
Migraine Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with episodic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
Migraine Long-term efficacy of fremanezumab in chronic and episodic migraine patients with acute medication overuse at baseline:results of a 1-year study
Migraine Long-term impact of fremanezumab on response rate, acute headache medication use, and disability in episodic migraine patients with acute medication overuse at baseline: results of a 1-year study
Migraine Burden of comorbid depression and anxiety on health-related quality of life in adult migraine patients in the United States
Migraine 10-year cost-effectiveness analyses of fremanezumab compared to erenumab as preventive treatment in episodic migraine for patients with inadequate response to prior preventive treatments
Migraine 10-year cost-effectiveness analyses of response-based fremanezumab use in migraine patients with inadequate response to prior preventive treatments
Migraine Safety and tolerability of fremanezumab in patients with migraine and documented inadequate response to 2-4 classes of migraine preventive medications in the international, multicenter, randomized, placebo- controlled FOCUS study
Migraine Patient satisfaction with fremanezumab treatment in migraine: results from a patient survey after completion of a 1-year extension study
Migraine Patient preference for dosing regimen and perception of dosing flexibility with fremanezumab for migraine: results from a patient survey following completion of a 1-year extension study
Migraine Patient preference for and satisfaction with fremanezumab following completion of a 1-year extension study
Page 22 of 25